Effect of Meal Composition on Postprandial Testosterone Concentration in Women With Polycystic Ovary Syndrome
NCT ID: NCT00455338
Last Updated: 2007-04-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2005-05-31
2006-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Meal Composition
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hyperandrogenemia - elevated total testosterone or free androgen index (ratio of testosterone/SHBG x 100). To participate in the study, women must have total testosterone \>50 ng/dL or a free androgen index \>1.5
* In good general health
Exclusion Criteria
* Use of confounding medications such as oral contraceptives or other hormonal medication, lipid lowering medications or insulin sensitizing agents such as metformin or the glitazones.
* Tobacco use
* Alcohol consumption of more than two drinks per day
* Unusual meal patterns (including no breakfast, breakfast before 6 am or breakfast after 10am.
* Untreated hyperprolactinaemia (Prolactin \>25ng/ml)
* Uncontrolled hypothyroidism
* History of blood clotting disorder
* Diagnosis of anemia at baseline visit
* Presence or history of diabetes mellitus
* Existence of an organic intra cranial lesion such as a pituitary tumor.
* Presence or history of coronary artery disease
19 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard S Legro, M.D.
Role: PRINCIPAL_INVESTIGATOR
Department of Obstetrics and Gynecology; Pennsylvania State University College of Medicine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
K24-HD0147-6
Identifier Type: -
Identifier Source: org_study_id